MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-KL-02-0054903
Molecular Radionuclidepharmacy Private Limited - healthcare in Ernakulam, Kerala, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹4,000
Latest filing
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Company age
12 yrs
Est. 2014
Directors on board
3
As per MCA filings
Last financials
Mar 2024
Balance sheet date
Last AGM
30 Sep 2024
Annual general meeting
Company status
Active
MCA master data
About Molecular Radionuclidepharmacy Private Limited
Data last updated:
Molecular Radionuclidepharmacy Private Limited is a private limited company based in Ernakulam, Kerala, India. It operates in the diagnostic centers and pathology labs segment of the healthcare sector. It was incorporated on 13 March 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U73100KL2014PTC036408.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Kizhakkebhagathu Ajith Joy (Managing Director) and Mibu Jose.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Xix/326 Kizhakkebhagathu Gardens Puthiyakavu Thripunithura P.O, Ernakulam, Kerala, India – 682301.
Molecular Radionuclidepharmacy Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-KL-02-0054903). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website molecularglobal.com.
Company details
CIN U73100KL2014PTC036408
Registration Number 036408
Incorporation Date 13 March 2014
ROC Ernakulam
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-KL-02-0054903
Recognitions & Rankings of Molecular Radionuclidepharmacy
Contact details
Molecular Radionuclidepharmacy Private Limited's registered office is in Ernakulam, Kerala. Its website is molecularglobal.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressXix/326 Kizhakkebhagathu Gardens Puthiyakavu Thripunithura P.O, Ernakulam, Kerala, India – 682301
- IndustryHealthcare, Diagnostic Centers & Pathology Labs
To see the full contact details of Molecular Radionuclidepharmacy Private Limited, buy the company report.
Comprehensive company report
Molecular Radionuclidepharmacy Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Molecular Radionuclidepharmacy is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Molecular Radionuclidepharmacy Private Limited, buy the company report.
Financials of Molecular Radionuclidepharmacy Private Limited
FY 2024 filings availableMolecular Radionuclidepharmacy Private Limited reported revenue of ₹4,000 for FY 2024.
Revenue · FY 2024
₹4,000
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Molecular Radionuclidepharmacy Private Limited, buy the company report.
Board of directors of Molecular Radionuclidepharmacy Private Limited
Molecular Radionuclidepharmacy has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mibu Jose | Director | 10 Jan 2024 | 2 Years 9 Months | Current |
| Kizhakkebhagathu Ajith Joy Also directs: Vellarimala Resorts LLP, Kizhakkebhagam Eco Tourism LLP, Kizhakkebhagam Agro Fisheries LLP and 5 more | Managing Director | 13 Mar 2014 | 12 Years 7 Months | Current |
| Smitha Ajith Also directs: Kizhakkebhagam Eco Tourism LLP, Kizhakkebhagam Agro Fisheries LLP, Kizhakkebhagam Estates LLP and 5 more | Director | 26 Apr 2021 | 5 Years 5 Months | Current |
Peer comparison
Molecular Radionuclidepharmacy Private Limited is compared with the 3 companies closest to it by revenue in the Healthcare industry (Diagnostics and Pathology Labs), with the same principal business activity (other hospital and medical care activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Molecular Radionuclidepharmacy Private Limitedthis company | ₹4,000 (FY 2024) | Ernakulam, Kerala, India | ||||
| Neuberg A. G Diagnostics Private Limited | ₹4,000 (FY 2025) | -100.0% | Mumbai, Maharashtra, India | |||
| Pic-Cell Imaging Private Limited | ₹3,500 (FY 2025) | -61.0% | Pune, Maharashtra, India | |||
| Acquity Labs Private Limited | ₹2,189 (FY 2025) | 14.0% | Bangalore, Karnataka, India |
To see the full peer comparison of Molecular Radionuclidepharmacy Private Limited, buy the company report.
Auditor
Molecular Radionuclidepharmacy Private Limited is audited by UNNIKRISHNAN & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| UNNIKRISHNAN & CO | FY 2023 | 004460S |
Shareholding
The shareholding of Molecular Radionuclidepharmacy Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Molecular Radionuclidepharmacy Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Molecular Radionuclidepharmacy Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Molecular Radionuclidepharmacy Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Molecular Radionuclidepharmacy Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Molecular Radionuclidepharmacy Private Limited has 6 board changes on record since 2014: 3 appointments and 3 cessations. The latest: Mibu Jose ceased to be Additional Director on 13 Oct 2024.
Ceased
Mibu Jose ceased to be Additional Director.
AGM
Molecular Radionuclidepharmacy Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Molecular Radionuclidepharmacy Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ernakulam.
Appointed
Mibu Jose was appointed as Director.
Ceased
Smitha Ajith ceased to be Additional Director.
Ceased
Mathew Francis Kattukkaran ceased to be Director.
Appointed
Smitha Ajith was appointed as Director.
Appointed
Kizhakkebhagathu Ajith Joy was appointed as Managing Director.
Incorporation
13 Mar 2014
Molecular Radionuclidepharmacy Private Limited was registered on 13 Mar 2014 with Roc Ernakulam & aged 12 years 7 months as per MCA records.
Frequently asked questions
Molecular Radionuclidepharmacy is an active private limited company based in Ernakulam, Kerala, India. The company works in diagnostic centers and pathology labs, within the healthcare industry. It was incorporated on 13 March 2014 (12+ years old) and is registered under CIN U73100KL2014PTC036408.
Molecular Radionuclidepharmacy has 3 current directors:
- Kizhakkebhagathu Ajith Joy - Managing Director
- Mibu Jose - Director
- Smitha Ajith - Director
The latest financial statements of Molecular Radionuclidepharmacy on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Molecular Radionuclidepharmacy is U73100KL2014PTC036408. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Molecular Radionuclidepharmacy was incorporated on 13 March 2014, making it 12+ years old. It is registered with the Registrar of Companies, Ernakulam.
The peers of Molecular Radionuclidepharmacy by revenue are Neuberg A. G Diagnostics Private Limited, Pic-Cell Imaging Private Limited, Acquity Labs Private Limited, all in the Healthcare industry (Diagnostics and Pathology Labs), with the same principal business activity (other hospital and medical care activities).
Mibu Jose ceased to be Additional Director on 13 Oct 2024. Mibu Jose was appointed as Director on 10 Jan 2024. Smitha Ajith ceased to be Additional Director on 30 Nov 2021. Molecular Radionuclidepharmacy has 6 board changes on record in total.
Yes, Molecular Radionuclidepharmacy is registered as a micro enterprise under Udyam registration (number: UDYAM-KL-02-0054903).
Molecular Radionuclidepharmacy can be reached through the website molecularglobal.com. Its registered office is in Ernakulam, Kerala, India.
The registered office of Molecular Radionuclidepharmacy is at Xix326 Kizhakkebhagathu Gardens Puthiyakavu Thripunithura P.O, Ernakulam, Kerala, India – 682301.
Molecular Radionuclidepharmacy operates in the healthcare industry, in the diagnostic centers and pathology labs segment.